Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients
Tiffany Thomas(Columbia University), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), James C. Zimring(University of Virginia), Travis Nemkov(University of Colorado Anschutz Medical Campus), Steven L. Spitalnik(Columbia University Irving Medical Center), Kirk C. Hansen(University of Colorado Anschutz Medical Campus), Davide Stefanoni(University of Colorado Anschutz Medical Campus), Aaron Issaian(University of Colorado Anschutz Medical Campus), Monika Dzieciątkowska(University of Colorado Anschutz Medical Campus), Eldad A. Hod(Columbia University), Paul W. Buehler(University of Maryland, Baltimore), Krystalyn E. Hudson(Columbia University Irving Medical Center), Richard O. Francis(Columbia University Irving Medical Center), Ryan C. Hill(University of Colorado Anschutz Medical Campus)
Cited by 292
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
|JCI Insight|2020|600
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
|Cancer Cell|2018|565
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556